Physician profile
Mark D Hartman
NPI 1801868252
$7,281.16
in general payments reported to CMS, 2019-2025
8 companies · $1,756 in 2025
The $1,756 reported for 2025 was more than what 89% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $792 · 2021: $275 · 2022: $3,234 · 2023: $408 · 2024: $522 · 2025: $1,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,719 · Travel and Lodging: $785 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,718.54 |
| Travel and Lodging | $785.03 |
| Education | $182.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,169.63 | 2019-2025 | Citrefix, Augment Injectable, Valor |
| Wardlow Enterprises | $1,747.26 | 2020-2022 | |
| Depuy Synthes Sales INC. | $138.94 | 2020-2024 | Na |
| Prism Medical | $124.86 | 2024-2025 | |
| Davol INC. | $30.47 | 2025 | Phasix Mesh |
| Organogenesis INC. | $29.12 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $29.03 | 2019-2021 | |
| Integra Lifesciences Corporation | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hartman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.